Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 4Phase 1 2Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 3Vitamin D Deficiency 1Smoldering Multiple Myeloma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1POEMS Syndrome 1Neuroblastoma 1Neoplasms, Plasma Cell 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia-Lymphoma, Adult T-Cell 1Immunoblastic Lymphadenopathy 1

Interventions

fludarabine 2Cyclophosphamide 2pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1pegaspargase 1dexamethasone acetate 1Tetrahydrouridine 1Surveys and Questionnaires 1Sugars 1Melphalan 1Loratadine 1Lenalidomide 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, T-Cell × Lenalidomide × Clear all
NCT00704691 2012-04-20

Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas

University of Alabama at Birmingham

Phase EARLY_PHASE1 Terminated
1 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡